Evolution Devices’ EvoWalk Device to Rehabilitate Walking Receives FDA 510(k) Clearance
The EvoWalk 1.0 System, designed to improve walking through AI-based functional electrical stimulation, now has FDA clearance.OAKLAND, CA / ACCESSWIRE...
Healthcare
Establishment Labs Announces Commercial Launch of Motiva Implants in China
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
Funding from new and existing investors including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, New...
3Daughters Successfully Closes Over $2 million in First Tranche of Seed Financing Round
Funding will accelerate development of a Novel IUD for contraception for IND filing in 2024MANSFIELD, Mass., Jan. 22, 2024 (GLOBE...
DLH to Announce Fiscal 2024 First Quarter Financial Results
ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and...
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice...
Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations
Inovalon's ScriptMed® Specialty Cloud-Based SaaS Solution Provides Data-Driven Analytics to Streamline Processes and Optimize Patient, Financial OutcomesBOWIE, Md., Jan. 22,...
SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D.
HUMMELSTOWN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based...
MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing
New Credit Facilities Provide Substantial Interest Savings and Access to Additional Capital to Support Execution of Strategic PrioritiesMARIETTA, Ga., Jan....
CloudMD to Present at Maxim Healthcare Conference
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2024) - CloudMD Software & Services Inc. (TSXV: DOC) (OTCQX: DOCRF) (FSE: 6PH)...
Evotec SE: Invitation to Conference Call
HAMBURG, GERMANY / ACCESSWIRE / January 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) is going...
Revolutionizing Healthcare: Remedy- House Calls Unveils Groundbreaking Platform for On-Demand, Personalized Care
New York, NY - Remedy - House Calls, a cutting-edge healthcare technology platform, is set to transform the landscape of...
InkSpace Imaging Announces Dr. E. Brian Welch, PhD, MBA as Vice President of Clinical Partnerships
PLEASANTON, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging today announced the appointment of Dr. E. Brian Welch, PhD,...
Registration Opens for 2024 Robotics Summit & Expo
Registration is now open for the Robotics Summit & Expo, the world’s leading technical event for commercial robotics developers. The...
Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
- 10,000-subject Phase 2b study would evaluate Vaxart’s next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine...
MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference
VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7)...
ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
MADRID, Spain and BOSTON, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical...
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
Sale of convertible notes provides additional financial flexibility and support for the Company’s path to cash flow breakevenTORONTO, Jan. 19,...
Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...
Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. (“Aimei”) announced today that, commencing January 22,...